Mutant p53 subverts p63 control over KLF4 expression in keratinocytes

Autor: S. Borrelli, Emilio Berti, Daniela Alotto, Elena Martynova, Daniele Fanoni, Roberto Mantovani, Carlotta Castagnoli, M A Viganò, Silvia Pozzi, Nicoletta Cordani
Přispěvatelé: Cordani, N, Pozzi, S, Martynova, E, Fanoni, D, Borrelli, S, Alotto, D, Castagnoli, C, Berti, E, Viganò, M, Mantovani, R
Jazyk: angličtina
Rok vydání: 2011
Předmět:
Keratinocytes
Cancer Research
Chromatin Immunoprecipitation
Skin Neoplasms
Cellular differentiation
Mutant
Blotting
Western

Kruppel-Like Transcription Factors
Fluorescent Antibody Technique
Gene Expression
keratinocyte
Biology
Transfection
Kruppel-Like Factor 4
stomatognathic system
Gene expression
MED/35 - MALATTIE CUTANEE E VENEREE
Genetics
medicine
Humans
Promoter Regions
Genetic

Molecular Biology
p63
Microscopy
Confocal

integumentary system
Activator (genetics)
Reverse Transcriptase Polymerase Chain Reaction
fungi
mutant p53
Membrane Proteins
Promoter
Cell Differentiation
Molecular biology
Immunohistochemistry
KLF4
HaCaT
medicine.anatomical_structure
Gene Expression Regulation
Tissue Array Analysis
embryonic structures
Mutation
Carcinoma
Squamous Cell

RNA Interference
sense organs
Tumor Suppressor Protein p53
Keratinocyte
Chromatin immunoprecipitation
Popis: Genetic experiments established that p63 is crucial for the development and maintenance of pluri-stratified epithelia and KLF4 for the barrier function of the skin. KLF4 is one of the factors that reprogram differentiated cells to iPS. We investigated the relationship between p63 and KLF4 using RNA interference, overexpression, chromatin immunoprecipitation and transient transfections with reporter constructs. We find that p63 directly represses KLF4 in normal keratinocytes (KCs) by binding to upstream promoter sites. Unlike p63, KLF4 levels are high in the upper layers of human skin and increase upon differentiation of KCs in vitro. In HaCaT KCs, which harbor two mutant alleles of p53, inactivation of p63 and of mutant p53 leads to KLF4 repression. p63 and p53 mutants are bound to sites in the KLF4 core promoter. Importantly, expression of the H179Y and R282Q p53 mutants in primary KCs is sufficient to activate endogenous KLF4. Finally, immunohistochemical analysis of tissue arrays confirms increased coexpression of KLF4 and mutant p53 in squamous cell carcinomas. Our data indicate that suppression of KLF4 is part of the growth-promoting strategy of p63 in the lower layers of normal epidermis, and that tumor-predisposing p53 mutations hijack p63 to a different location on the promoter, turning it into an activator of this reprogramming factor.
Databáze: OpenAIRE